mitoxantrone has been researched along with Bacteremia in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Because both P-glycoprotein- and platinum-induced resistance appear to be clinically important and can be reversed in vitro with a short exposure of cyclosporin A (CSA) at 2000 and 5000 ng/ml, respectively, we undertook a trial of high-dose chemotherapy with carboplatin (1500mg/m2), mitoxantrone (75 mg/m2), and cyclophosphamide (120 mg/kg) over a 5-day period combined with escalating doses of CSA." | 2.68 | High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. ( Bayer, R; Camarda, M; Kinch, L; Loutfi, S; Peace, D; Rad, N; Sosman, J; Stiff, PJ; Tan, S, 1995) |
| "Neutropenia was present in 74." | 1.32 | Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. ( Creutzig, U; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Reinhardt, D; Varwig, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roy Moulik, N | 1 |
| Keerthivasagam, S | 1 |
| Velagala, SV | 1 |
| Gollamudi, VRM | 1 |
| Agiwale, J | 1 |
| Dhamne, C | 1 |
| Chichra, A | 1 |
| Srinivasan, S | 1 |
| Shetty, D | 1 |
| Jain, H | 1 |
| Subramanian, PG | 1 |
| Tembhare, P | 1 |
| Chatterjee, G | 1 |
| Patkar, N | 1 |
| Narula, G | 1 |
| Banavali, S | 1 |
| Lehrnbecher, T | 1 |
| Varwig, D | 1 |
| Kaiser, J | 1 |
| Reinhardt, D | 1 |
| Klingebiel, T | 1 |
| Creutzig, U | 1 |
| Khalil, A | 1 |
| Ciobanu, N | 1 |
| Sparano, JA | 1 |
| Gucalp, R | 1 |
| Dutcher, JP | 1 |
| Wiernik, PH | 1 |
| Brodsky, AL | 1 |
| Melero, MJ | 1 |
| Minissale, CJ | 1 |
| Sánchez Avalos, JC | 1 |
| Stiff, PJ | 1 |
| Bayer, R | 1 |
| Tan, S | 1 |
| Camarda, M | 1 |
| Sosman, J | 1 |
| Peace, D | 1 |
| Kinch, L | 1 |
| Rad, N | 1 |
| Loutfi, S | 1 |
3 trials available for mitoxantrone and Bacteremia
| Article | Year |
|---|---|
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignancies.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Trans | 1995 |
[Chemotherapy schedules and bacteremia in adult patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Anti | 1996 |
High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carb | 1995 |
2 other studies available for mitoxantrone and Bacteremia
| Article | Year |
|---|---|
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, India.
Topics: Bacteremia; Child; Hospitals; Humans; India; Mitoxantrone; Prospective Studies; Retrospective Studie | 2023 |
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteria; Chi | 2004 |